Genetics of Appendix Cancer Study

Description

The GAP Study is a prospective cohort study designed to comprehensively investigate genetic variations that may contribute to cancer development among individuals diagnosed with appendix/appendiceal cancer who are ages 18+ years.

Conditions

Appendix Cancer, Appendiceal Cancer, Appendiceal Neoplasms, Appendiceal Mucinous Neoplasm, Appendiceal Adenocarcinoma, Appendiceal Carcinoid Tumor, Appendiceal Neoplasm Malignant Secondary, Appendix Adenocarcinoma, Appendix Mucinous Neoplasm, Appendix Tumor, Appendix Cancer Metastatic, Appendix NET, Low-Grade Appendix Mucinous Neoplasm, High Grade Appendix Mucinous Neoplasm, High Grade Appendix Mucinous Adenocarcinoma

Talk to us

Study Overview

On this page

Study Details

Study overview

The GAP Study is a prospective cohort study designed to comprehensively investigate genetic variations that may contribute to cancer development among individuals diagnosed with appendix/appendiceal cancer who are ages 18+ years.

Genetics of Appendix Cancer: The GAP Study

Genetics of Appendix Cancer Study

Condition
Appendix Cancer
Intervention / Treatment

-

Contacts and Locations

Nashville

Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States, 37232

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Known diagnosis of appendix cancer in the United States
  • * Mentally and physically able to consent and participate in the study
  • * Known diagnosis of appendix cancer
  • * Diagnosed by and/or consulting with a physician/clinical provider participating in the GAP Study
  • * Mentally and physically able to consent and participate in the study
  • * Biological parents (mother and/or father) of individuals actively participating in the GAP Study
  • * Residing in the United States
  • * Mentally and physically able to consent and participate in the study
  • * Women pregnant at the time of consent
  • * Prisoners
  • * Unable to provide informed consent
  • * Unable to read, write, or complete questionnaires in English

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Andreana Holowatyj, PhD, MSCI,

Andreana N Holowatyj, PhD, MSCI, PRINCIPAL_INVESTIGATOR, Vanderbilt-Ingram Cancer Center

Study Record Dates

2034-11